Cardiovascular Systems, Inc. (CSII): Price and Financial Metrics


Cardiovascular Systems, Inc. (CSII): $14.57

0.21 (+1.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CSII POWR Grades


  • Value is the dimension where CSII ranks best; there it ranks ahead of 72.85% of US stocks.
  • The strongest trend for CSII is in Quality, which has been heading down over the past 179 days.
  • CSII's current lowest rank is in the Growth metric (where it is better than 7.19% of US stocks).

CSII Stock Summary

  • The ratio of debt to operating expenses for Cardiovascular Systems Inc is higher than it is for about merely 14.03% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.28 for Cardiovascular Systems Inc; that's greater than it is for only 16.37% of US stocks.
  • The volatility of Cardiovascular Systems Inc's share price is greater than that of 86.94% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Cardiovascular Systems Inc are AXGN, BIOC, BDSX, GLBE, and TRUE.
  • CSII's SEC filings can be seen here. And to visit Cardiovascular Systems Inc's official web site, go to www.csi360.com.

CSII Valuation Summary

  • In comparison to the median Healthcare stock, CSII's price/sales ratio is 50.66% lower, now standing at 5.6.
  • Over the past 185 months, CSII's price/sales ratio has gone down 81.9.
  • CSII's price/sales ratio has moved down 81.9 over the prior 185 months.

Below are key valuation metrics over time for CSII.

Stock Date P/S P/B P/E EV/EBIT
CSII 2021-08-31 5.6 5.3 -107.2 -121.4
CSII 2021-08-30 5.4 5.2 -105.1 -118.9
CSII 2021-08-27 5.5 5.3 -106.0 -120.0
CSII 2021-08-26 5.4 5.2 -105.0 -118.8
CSII 2021-08-25 5.5 5.3 -106.4 -120.4
CSII 2021-08-24 5.6 5.4 -108.4 -122.8

CSII Growth Metrics

    The 4 year price growth rate now stands at 161.95%.
  • The 2 year price growth rate now stands at 43.96%.
  • The year over year revenue growth rate now stands at -12.09%.
CSII's revenue has moved up $46,983,000 over the prior 52 months.

The table below shows CSII's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 251.765 -12.732 -28.874
2021-09-30 256.799 -9.506 -19.963
2021-06-30 258.973 -0.884 -13.421
2021-03-31 230.532 -13.761 -23.302
2020-12-31 228.434 -11.452 -20.187
2020-09-30 232.599 -9.207 -23.532

CSII's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CSII has a Quality Grade of B, ranking ahead of 75.78% of graded US stocks.
  • CSII's asset turnover comes in at 0.745 -- ranking 42nd of 186 Medical Equipment stocks.
  • NVRO, KRMD, and CRY are the stocks whose asset turnover ratios are most correlated with CSII.

The table below shows CSII's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.745 0.764 -0.051
2021-03-31 0.670 0.780 -0.109
2020-12-31 0.731 0.786 -0.110
2020-09-30 0.827 0.791 -0.161
2020-06-30 0.945 0.794 -0.232
2020-03-31 1.192 0.801 -0.078

CSII Price Target

For more insight on analysts targets of CSII, see our CSII price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $45.88 Average Broker Recommendation 1.65 (Moderate Buy)

CSII Stock Price Chart Interactive Chart >

Price chart for CSII

CSII Price/Volume Stats

Current price $14.57 52-week high $43.37
Prev. close $14.36 52-week low $13.41
Day low $14.22 Volume 266,400
Day high $15.12 Avg. volume 389,127
50-day MA $16.07 Dividend yield N/A
200-day MA $21.90 Market Cap 594.24M

Cardiovascular Systems, Inc. (CSII) Company Bio


Cardiovascular Systems develops, manufactures, and markets devices for the treatment of vascular diseases, targeting a range of plaque types in leg arteries above and below the knee. The company was founded in 1989 and is based in St. Paul, Minnesota.


CSII Latest News Stream


Event/Time News Detail
Loading, please wait...

CSII Latest Social Stream


Loading social stream, please wait...

View Full CSII Social Stream

Latest CSII News From Around the Web

Below are the latest news stories about Cardiovascular Systems Inc that investors may wish to consider to help them evaluate CSII as an investment opportunity.

Cardiovascular Systems, Innova Vascular team up for thrombectomy devices

Cardiovascular Systems (NASDAQ:CSII) has collaborated with Innova Vascular to develop a full line of novel thrombectomy devices. Thrombectomy is an interventional procedure performed to remove blood clots from arteries and veins. The company intends to acquire and commercialize novel thrombectomy devices from Innova targeting peripheral vascular disease, including deep vein thrombosis...

Seeking Alpha | February 23, 2022

Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices

ST. PAUL, Minn., February 23, 2022--Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices

Yahoo | February 23, 2022

Cardiovascular Systems' (CSII) Q2 Earnings Lag Estimates

Cardiovascular Systems (CSII) exhibits a robust performance by its worldwide coronary franchise despite challenging business climate.

Yahoo | February 4, 2022

Cardiovascular Systems GAAP EPS of -$0.23 misses by $0.09, revenue of $59.1M misses by $3.56M, cuts FY guidance

Cardiovascular Systems press release (NASDAQ:CSII): Q2 GAAP EPS of -$0.23 misses by $0.09. Revenue of $59.1M (-7.9% Y/Y) misses by $3.56M. For the fiscal year ending June 30, 2022, CSI anticipates: Revenue of $235 million to $245 million from prior guidance of $265 million to $285 million vs. $270.17M consensus. Gross profit...

Seeking Alpha | February 3, 2022

Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q2 2022 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 3, 2022

Read More 'CSII' Stories Here

CSII Price Returns

1-mo -9.11%
3-mo -36.43%
6-mo -27.66%
1-year -65.85%
3-year -65.97%
5-year -54.71%
YTD -22.42%
2021 -57.08%
2020 -9.94%
2019 70.55%
2018 20.26%
2017 -2.15%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6502 seconds.